United States

Alzheimer’s disease (AD) is the most common form of dementia, accounting for 70 to 80% of all cases. The greatest risk factor for AD is aging; an estimated 30 million people are living with AD and over the next 30 years it is projected to increase to over 130 million worldwide. In addition, one in three seniors have died of AD or another dementing disease, and since 2000, deaths from Alzheimer’s disease have increased 89%. TDP-43 is the major pathological protein in motor neuron disease and frontotemporal dementia. Previously, TDP-43 pathology has been reported that in up to 50% of late-onset, sporadic cases of Alzheimer’s disease, the TDP-43 protein has been reported as an age-related co-pathology linked to dementia severity. TDP-43 proteinopathy in those over 80 has recently been recognized as an independent disease entity, limbic- predominant age-related TDP-43 encephalopathy (LATE). There are over one million people living with LATE in the United States. As LATE shares some of the clinical features of dementia seen in AD in addition to co-existing with AD, understanding mechanisms leading to the pathogenesis of LATE and co-morbid TDP-43 pathology could lead to the development of targeted therapeutics. We have developed an inducible cell-specific pathological model by introducing three familial ALS mutations in the human TDP-43 gene(3XTDP43). Utilizing the tetracycline inducible system, we drove 3XTDP43 specifically in the hippocampus (Camk2a-tTA). Ten-month old mice were used in this study where we performed fMRI, histology, Western blot, and solubility fractionations. Results show phosphorylated TDP-43 pathology and a distinct decrease in solubility. In addition, 3XTDP43 overexpression increases phosphorylation of endogenous tau which may indicate aggregation. Though the mice were imaged (fMRI) we have not evaluated those results as of yet. This model may provide a better understanding of the pathogenesis of TDP-43 proteinopathies.

DSU Summer Research Symposium 2021

Selective Expression of Triple Mutant TDP-43 in the Hippocampus Increases Phosphorylate Tau

Advancing the professions of speech-language pathology and audiology through education, advocacy, leadership, and collaboration to promote quality services for individuals and communities.

Early registration pricing available through October 5.  Registration for this event closes on October 11. 

OSHA Members:  Please log into your OSHA member account to access the member registration rates! There is no registration code required for OSHA Members if logged into your OSHA member account. 

Registration Is Required

OSHA 2022

Advancing the professions of speech-language pathology and audiology through education, advocacy, leadership, and collaboration to promote quality services for individuals and communities.

poster

Welcome to Delaware State University’s Annual Summer Research Symposium, and thank you for attending! Our symposium represents the culmination of students’ summer experiences in research at Delaware State University. This event showcases the work of college students working on faculty-led research projects, as well as middle and high school students experiencing research for the first time working in research groups. Whatever the case, this summer has been a unique experience for the students, and we hope a transformative one. Even for students who are not planning a career in scientific research, their summer experience has given them skills they will draw on for years to come. 
 Please join us on the mainstage and in Gather for the live event, and visit the recorded poster presentations any time.
 The student participants and organizers of the various summer programs at DSU would like to thank all of the research mentors who guided our summer program participants. There were many DSU faculty, graduate students, and other research and program staff who gave their time and energy to help our students have a fun and educational summer experience. Without their generosity and patience these summer programs would not be possible.
 For the research participants, we hope that you will maintain contact with your research mentors and colleagues. Science is a relatively small community made up of disciplinary “neighborhoods”. If you continue to work in a discipline, the other folks in that discipline will be like your neighbors that you run into regularly. Staying in contact with them will help you keep up with the news of the neighborhood, and open doors to educational and career opportunities. Whether you continue in science or take a different career path, for this summer you have been part of the world of research, and you will benefit from that perspective for the rest of your life.

Please register for the DSU Summer Research Symposium 2021 to be able to access the content.  
If you have already registered, please login with the same email you used to registered for the Conference.

Welcome to Delaware State University’s Annual Summer Research Symposium, and thank you for attending!

Parkinson’s Disease (PD) is a central nervous system disorder which causes motor control issues. Current medications help improve the quality of life of those with Parkinson’s by relieving some symptoms, but do not prevent the progression of the disease. A key sign of PD is the formation of Lewy bodies in the striatum and substantia nigra. Lewy bodies are a result of protein aggregation in the brain and a major component of these Lewy bodies is the protein α-synuclein, which is known to undergo many post-translational modifications, one of which being SUMOylation. Small ubiquitin-like modifiers (SUMO) can post-translationally modify proteins affecting their function and stability in a process known as SUMOylation(1). SUMO specific proteases (SENPs) are enzymes which play a role in the de-conjugation of SUMO proteins, making the process of SUMOylation a reversible one(2). In this study, we test the possibility of applying the inhibition of SENPs as a potential treatment for Parkinson’s disease. We tested a natural SENP1 inhibitor, Momordin Ic and a chemical inhibitor, S2A, in PFF treated cells. We have found that both SENP inhibitors are efficacious in reducing cytotoxicity and increasing cell viability after PFF-induced stress. Our results strongly suggest the potential use of the SENP1 inhibitors, S2A and Momordin, as a therapeutic application for Parkinson’s disease.

SUMO Protease1 (SENP1) Inhibitor as a Potential Therapeutic for Parkinson’s Disease

Neurons and Astrocytes are two key components to our brain’s way of relaying information. When several neurons fire action potential at the same time it is called neuronal synchronizing. This is implicated in many neuronal functions that occur during development- synaptic plasticity, establishment of functional neural networks, as well as pathological conditions such as epileptic seizures. Preliminary data gathered by my lab showed that astrocyte-neuron interactions are important for development of neuronal synchronous activity in developing vertebrate brains. We focused primarily on the astrocytic model of G-Protein Coupled Receptors (GPCR)-mediate calcium induced calcium release (CICR). Our model proposes that CICR in astrocytes is controlled by mGluR1, a metabotropic glutamate receptor that leads to the release of glutamate. To demonstrate this we cultured primary astrocytes from optic tectum dissection as well as Human Embryonic Kidney (HEK) Cells . The HEK cells were transfected with melanopsin and GCaMP

An Optogenetic Approach To Understand Molecular Mechanisms of Astrocyte-​Neuron Interactions in the Development of Neuronal Synchrony

The Biopac Student Lab (BSL) is a proprietary educational system, integrating hardware and software for the acquisition of physiological electrical signals from human bodies. In a prior study, we recorded the electroencephalogram (EEG) or brainwaves from a group of volunteers to study how 432 and 440 Hz music tuning may affect responses in human brains. However, the analysis was conducted using the rudimentary built-in functions on BSL with very limited options for EEG analysis and the patterns were not definitive. In this project, our goal is to export data from BSL to a more advanced system AcqKnowledge, which provides specialized EEG analysis capabilities such as approximate entropy, delta power analysis, alpha RMS, etc. We were able to export raw data from BSL to AcqKnowledge of combined EEG signals as well as four channels including alpha, beta, delta, and theta waves using delimited text file with matching sample rate. We will further look into the literature and explore the EEG analysis capabilities on AcqKnowledge in search for an effective strategy to analyze the existing and new data. We anticipate that more advanced analysis of EEG data will shed light on the impacts of music on human brains.

Exporting Data from Biopac Student Lab to AcqKnowledge for Advanced Analysis of Human Brainwaves In Response to Music Tuning

Human bodily functions, e.g., exhaled breath, perspiration, and physiological processes, exhibit several chemical and isotopic tracers that are potential disease signatures. Exhaled human breath analysis can be used for early disease detection and identify and discriminate disease biomarkers while being non-invasive. This project aims to develop rapid, real-time chemical and biological detection using mid-infrared laser systems. We used mid-infrared laser spectroscopy to detect the molecular absorption line transitions. In addition, we designed a long pathlength (30 m) Heriot Laser Optical Cavity to maximize the signal-to-noise ratio of experimental molecular absorption signals. This is a vital part of laser-based precision sensing. Furthermore, we also focused on a volatile organic compound and the detection of Nitrous Oxide (N2O). A rapid laser scan was performed at a frequency of 100 Hz with laser stabilized at a constant 27°C. This allowed us to estimate the current range, 50 mA to 72 mA, and the wavelength range of 4537 nm to 4540 nm of the mid-Infrared absorption from the molecular rotational-vibrational transitions. We also show that mid-infrared sensing is ideal for real-time precision detection of molecules. In addition, molecular density can be precisely estimated by the polynomial fitting of the absorption signal.

Laser-based precision sensing for biomedical applications

Dandelion (Taraxacum officinale) root extract (DRE) is known to have anti- cancer activity against breast cancer, leukemia, prostate cancer, colorectal cancer and melanoma cells (1-5). Even though this plant is sometime seen as a pesky weed in our culture, in other cultures such as Chinese, Middle Eastern, Native Americans, and East Indians, it is appreciated for its medicinal effects against cancer and other diseases ranging from indigestion, heartburn and kidney disease. Based on the reported anti-cancer cell activities of DRE, particularly on aggressive cancer cells but not on normal cells, we decided to study its activity on two breast cancer cell lines, one expressing the cell membrane receptor CD44 (i.e., MCF-7/CD44) and a control cell line negative for CD44 expression (i.e., MCF-7/pLXIN) (3, 6). The MCF-7/CD44 cell line is an aggressive multidrug resistant, very migratory and in vitro invasive while the MCF-7/pLXIN cell line is not. We hypothesize that aqueous DRE will have differential anti-cancer cell activity on these two cell lines based on their CD44 expression status. A cell viability assay (MTS) carried out after 48 hrs of DRE treatment showed that MCF-7/CD44 cells were more sensitive to DRE (when extracted in boiled PBS) compared to MCF-7/pLXIN cells. Treatment of these cell lines with non-boiled PBS extracted DRE showed no cell toxicity effect. This data validated our hypothesis and suggest that DRE might be effective at targeting CD44-expressing aggressive breast cancer cells.

Effects of Dandelion Root Extract (DRE) on CD44(+) and CD44(-) for Cell Viability

We report Raman spectroscopy measurements on samples of Ficoll polysaccharide dissolved in water at different concentrations (up to 1000 mg/ml) and collected at ambient temperature. The goal is to identify and assess Raman spectral signatures associated with the molecular structure of Ficoll PM70 and the concentration effect on these signatures. Raman spectroscopy is used to determine molecular vibrational modes, providing spectral peaks that identify the molecules (e.g Ficoll), especially in crowded and multicomponent matrices. Here, an excitation laser beam is directed onto the solution sample and interact with the structural vibrational modes of the macromolecules, resulting in energy shift of the laser photons that can be readily measured. Ficoll is accepted as a water-soluble, neutral, highly branched polymer and is commonly applied as a macromolecular crowding agent in diverse studies of protein folding and stability as well as cell volume signaling. Further, it is also used to separate blood into its components such as leukocytes and erythrocytes. In our case, we have been using Ficoll as a model crowded system to investigate the complex behavior of diverse nanoparticles. We used a HORIBA MacroRAM spectrometer to measure the Raman spectra of Ficoll solutions. In addition to the commonly reported Raman peaks of water (~1640 cm-1 HOH bend; ~3200 cm-1 OH stretching band) and possibly dissolved O2 (~1556 cm-1) and N2 (~2331 cm-1) we have identified four distinct spectral peaks (~1270 cm-1 ,~1350 cm-1,~1460 cm-1, ~2900 cm-1) likely associated with Ficoll in the 1000 to 3500 cm-1 wavenumber range, a range set to avoid possible spectral contamination from the quartz sample holder. Increase of the Ficoll concentration shows systematic increase of the intensity of the observed Ficoll peaks and systematic decrease in intensity of the two peaks associated with water, the latter effect being due likely to reduction of water content. These observations and a detailed analysis and interpretation of the measured spectral information enclosed in the Raman emission of Ficoll macromolecules may lead to a better understanding of the complexity in chemical analysis of crowded biopolymeric samples.

Raman Spectra of Concentrated Ficoll Solutions

Parkinson’s Diseases (PD) is the second most common neurodegenerative disorder and is characterized by a preferential loss of dopaminergic neurons of the substantia nigra pars compacta. The cause of the disease remains unknown; however, it is thought that environmental factors may contribute to its development. Rotenone is a pesticide that blocks mitochondrial respiration in the Electron Transport Chain by inhibiting Complex I and has been identified as an environmental risk factor for sporadic PD. Here our goal is to develop strategies that can lead to the development of potential preventative measures against PD. Dacarbazine is a potential anti-PD drug that is known for its use in chemotherapy for skin cancer and was identified in a previous screen for neuroprotective agents against the disease. We hypothesize that Dacarbazine can relieve or reverse the effects of rotenone in Drosophila. We set up a study to analyze the effect of dacarbazine against rotenone-induced neurotoxicity using locomotion behavior as a measure of neuronal toxicity. We set up four conditions: rotenone only; rotenone combined with dacarbazine; dacarbazine only; and DMSO only as vehicle only control. Here we present our results in two paradigms: a first one in which we performed a brief chronic exposure to rotenone and/or dacarbazine for three weeks and a second paradigm in which the chemical treated flies were allowed to recover on normal food for two additional weeks. Together, these studies could help determine whether dacarbazine confers protection against rotenone-induced neurotoxicity and could inform future efforts to establish a neuroprotective strategy against sporadic PD.

Ameliorating the effects of an environmental toxin in a Drosophila model of Parkinson’s Disease

Parkinson’s Disease (PD) is a common neurodegenerative disease. Although not fully understood, we do know that the alpha-synuclein protein plays a major role in causing PD. α-syn Drosophila flies overexpress the α-syn protein which it normally does not express. This allows it to be used as a model for studying Parkinson’s Disease. Gal4 is a driver that allows for the expression of α-syn. For this project, a cross of GAL4 Drosophila and α-syn Drosophila was compared to two control groups to develop a model. One control group was Gal4 crossed into wild-type background. The second control group was UAS-aSyn crossed into wild-type background. To develop the different variations, female drosophila were collected and crossed with adult male drosophila. Over a period of 8 days, the first generation offspring from the three groups were collected and divided into flies separated by sex. We ran locomotion assays using MWT (Multi-Worm Tracker) to track the movement of the flies. The males appeared to be moving at a slower rate than the females. We recorded survival, tracking the number of flies in each vial twice a week. On the 6th week of survival, there was a dramatic drop in the number of flies. Also, both female and male GAL4 x A-SYN Drosophila had similar survival rates. Once we develop a model we will use the model to run an experiment using PFF (Preformed Fibrils) to essentially test whether or not the overexpression of the α-syn gene protects the drosophila from getting Parkinson’s.

The Development of a Model to Study Genetic Parkinson’s Disease using Alpha-synuclein overexpressing Drosophila

Parkinson’s disease (PD) is the most prevalent neurodegenerative motor disease, mostly occurring in people over the ages of 65 years. Protein aggregation known as Lewy body is the hallmark for dopaminergic neuronal death in Parkinson’s disease pathology(1). PD patients initially experience motor deficits such as tremors and postural instability. As the disease progresses, patients lose complete control of physiological functions, which ultimately causes death. The current drugs available for the treatment of PD only alleviates the symptoms by boosting dopamine levels, but do not halt neurodegeneration. The main objective of this study is to evaluate the efficacy of a novel compound-6 by AptaBio as a potential therapeutic for Parkinson’s disease treatment. We analyzed whether this compound was efficacious in reducing PFF (Preformed fibrils of alpha-synuclein)-induced toxicity in N27 dopaminergic cells(3). The compound-6 not only enabled to increase cell viability and reduce cytotoxicity in vitro, but also reduced oxidative stress and minimized protein aggregation. We first tested the compound using a transgenic mouse model known as line 61(3). We demonstrate that the compound-6 successfully decreased motor deficits with stabilizing the levels of dopamine. However, we wanted to use an in vivo model that was more suitable to showcase the compound’s capability of halting neurodegeneration. Hence, we chose to use the PFF injected mouse model. Sonicated PFF was stereotaxically injected to the striatum of C57BL/6 male and female mice bilaterally (aged around 12 months). The PFF injection increases the phosphorylated alpha-synuclein and causes protein aggregation(2). After 4 to 5 months post injection, mice started showing Parkinsonian symptoms in behavior. At this stage, we gavaged the mice with the AptaBio compound-6 at two different doses of 5mg/kg and 25 mg/kg for 5 weeks. After gavaging we performed multiple behavioral tests such as hindlimb clasping, pole test, rotarod, nesting and grooming to measure whether motor function improved with the treatment as compared to PFF injected group that wasn’t treated. There was another group that was only injected with PBS, which was considered as positive controls since they do not show any motor deficits. Currently, we have finished all the behavioral tests and are finishing up data analysis for next 2 weeks. Taken together, our results are promising to show that the AptaBio compound-6 can be a novel and effective treatment for PD by halting neurodegeneration and promoting neuronal recovery.

AptaBio Compound-6 As a Potential Therapeutic for Parkinson’s disease models

Different studies show that TDP-43 plays a major role in association with other neurological diseases, however, we want to test why TDP-43 is a major factor. We injected a mouse with TDP-43 and injected another mouse with Alzheimer's Disease. The two mice were watched for more than over a month now. We used the mice's pellets to conduct the different tests we ran. We sonicatied the different mice pellets for a 1 min 20 minutes with a 5 sec pulse and 5 sec off cycle. Once the sonication was done, we transferred the sonicated pellets to the centrifuge machine which ran for about 35 minutes. Other graduate students began to compare results from these batches of pellets to the others that they tested to see the difference or similarities. These results showed us that the Alzheimer's disease mouse model that we developed over expresses pathological tau and TDP-43.

Selective Expression of Triple Mutant TDP-43 in the Hippocampus Increases Phosphorylate Tau

Downloads

Next from DSU Summer Research Symposium 2021

SUMO Protease1 (SENP1) Inhibitor as a Potential Therapeutic for Parkinson’s Disease

Similar lecture

Evaluating Student Outcomes in an Aphasia Escape Room Simulation

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES